Professor of Public Health Policy and Practice
areas of expertise
Marie Claire Van Hout is Professor of Public Health Policy and Practice at the Public Health Institute, Liverpool John Moore’s University, United Kingdom. She has over 17 years research, education, community development and clinical practice experience in various fields of public health and drug policy and practice, and concentrated in the area of prescribed and illicit substance use, misuse and dependence, HIV/HCV prevention, treatment, care and support in Europe and Sub Saharan Africa, performance and image enhancement, and Travellers and Gypsy health. Her international reputation as a recognised leader in her field of has led to a number of significant honorary appointments and collaborations. These include; Associate Member of Staff at the Alcohol, Tobacco and Other Drug Abuse Research Unit of the South African Medical Research Council, South Africa since 2010; Visiting Research Fellow at Department of Health, Psychology and Social Care, Glyndŵr University, UK since 2012; Visiting Research Fellow at the Public Health Institute, Liverpool John Moore’s University, UK 2014-2017; Visiting Professor at the Centre for Research and Studies in Sociology, University Institute of Lisbon (CIES-IUL) and Visiting Professor at the Institute for Drug and Alcohol Studies (IDAS) at Virginia Commonwealth University (VCU), USA since 2016. She has consulted for the United Nations Office on Drugs and Crime (UNODC), the European Monitoring Centre for Drugs and Drug Addiction (ENCDDA) (2012), and the European Research Executive Agency (REA). She has been Editor in Chief of the ‘Journal of Ethnicity in Substance Abuse’ at Taylor and Francis since 2014. Marie Claire is currently part of the supervisory team for two of our PhD students, Jennifer Brizell and Charlotte McLean, who are undertaking research into the female use of enhancement drugs.
Professor Marie Claire Van Hout's Papers
Professor Marie Claire Van Hout, C Claffey, M MacLachlan, Des Crowley
Heroin Addiction And Related Clinical Problems, 19 (6). ISSN 1592-1638, 2017.
Abstract: The Irish Travelling community are identified “as a people with shared history, culture and traditions including, historically, a nomadic way of life”. The core of Travelling culture is strong family bonds which support resilience, however changing social circumstances and dislocation have contributed to significant mental and physical health issues accompanied by a steep rise in substance abuse and addiction.
Experiences of Codeine Use, Misuse and Dependence: Application of Liese and Franz’s Cognitive Developmental Model of Substance Abuse.
Professor Marie Claire Van Hout, Ian Norman, Eileen Rich, Michael Bergin
Behavioural and Cognitive Psychotherapy, 45(3), 238-252. doi:10.1017/S1352465817000030, 2017.
Abstract Misuse of codeine-containing medicines is an emerging public health issue.
Professor Marie Claire Van Hout, Amneh Al-Husseini, Mayyada Wazaify
International Journal of Mental Health and Addiction, 1-13. doi:10.1007/s11469-017-9813-4, 2017.
Abstract Pregabalin is currently approved for the treatment of epilepsy, generalized anxiety disorder, neuropathic pain, and fibromyalgia. A qualitative study was undertaken in Jordan, where concerns have been raised about its unprescribed availability in community pharmacies and thereby its abuse. Semi-structured interviews were conducted with all patients with a history of pregabalin use in two Jordanian addiction treatment centers. All were male patients aged 21–30 years (n = 11). The majority was poly-drug abusers and had a previous history of substance abuse (tramadol, Captagon, synthetic cannabinoids, and marijuana). Six key themes emerged from a content textual analysis which centered on pregabalin and other drugs; the pregabalin effect; poly-pharming and pregabalin intoxication; trajectories, patterns, and routes of administration; dependence and withdrawal; and sourcing of pregabalin. The study underscores the need for continued pharmacovigilance to manage and address suspected abuse, along with community pharmacist and patient education regarding abuse liability and related harms.